PROSPECTIVE RANDOMIZED CONTROLLED TRIAL OF COMBINATION RANIBIZUMAB (LUCENTIS) AND BROMFENAC (XIBROM) FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Pilot Study : RETINA

Secondary Logo

Journal Logo

Original Study

PROSPECTIVE RANDOMIZED CONTROLLED TRIAL OF COMBINATION RANIBIZUMAB (LUCENTIS) AND BROMFENAC (XIBROM) FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

A Pilot Study

Flaxel, Christina MD; Schain, Mitchell B BS; Hamon, Sara C PhD; Francis, Peter J MD, PhD

Author Information
Retina 32(3):p 417-423, March 2012. | DOI: 10.1097/IAE.0b013e318229b0af

Abstract

© 2012 by Ophthalmic Communications Society, Inc.

You can read the full text of this article if you:

Access through Ovid